Lab-grown immune cells take on lung cancer in new trial
NCT ID NCT07202611
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This early-phase study tests whether specially grown immune cells (dendritic and natural killer cells) from a patient's own blood are safe for treating advanced non-small cell lung cancer. Ten participants who have already tried at least two standard treatments will receive the cells through injections into a lymph node and a vein. The main goal is to check for side effects, while also measuring how well the cells can kill cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Yunlin Branch
RECRUITINGHuwei, YUNLIN, 640, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.